A股異動 | Q4收入增長提速 涪陵榨菜(002507.SZ)放量漲停
格隆匯2月25日丨涪陵榨菜(002507.SZ)漲停,報34.17元,暫成交5.2億元遠超昨日成交額,總市值303.3億元。公司去年歸母淨利潤7.42億元,同比下降4.53%。其中,Q4單季歸母淨利潤2.38億元,同比增長45.73%。中信建投點評稱,公司Q4收入增長提速,費用收縮後利潤表現超預期。另外,Q4實施提價,能夠直接帶動毛利率改善。預計對今年公司的收入也能有兩位數左右的增長貢獻,保證整體銷售穩健向好。公司去年藉助調味品行業提價潮,進行產品價格調整,在優化自身毛利率的同時,也增厚了渠道利潤,利好今年公司實現收入利潤的雙重提振。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.